Milnacipran Hydrochloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Milnacipran Hydrochloride
US Patents

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2025-03-24

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Gentec Pharmaceutical Group is focused on manufacturing & developing APIs/HPAPIs, Advanced Intermediates & Fine Chemicals.

Contact Supplier

xyz-pharma-m-2025-03-17

Contact Supplier

Milnacipran Hydrochloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 15 USDMF, 5 JDMF, 7 EU WC, 2 KDMF, 6 NDC API, 8 Listed Suppliers, $ API Reference Price

23 API Suppliers
15 USDMF
5 JDMF
7 EU WC
2 KDMF
6 NDC API
8 Listed Suppliers
$ API Reference Price

FINISHED DOSAGE FORMULATIONS

35 FDF Dossiers, 35 FDA Orange Book

35 FDF Dossiers
35 FDA Orange Book

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG, TABLET;ORAL - 12.5MG, TABLET;ORAL - 25MG, TABLET;ORAL - 50MG

TABLET;ORAL - 100MG
TABLET;ORAL - 12.5MG
TABLET;ORAL - 25MG
TABLET;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

5 DKSH, 2 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 1 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 3 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 18 BASF, 1 Clariant, 10 Corel Pharma Chem, 1 Finar, 6 Gangwal Chemicals, 6 Ideal Cures Pvt Ltd, 14 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 7 Microlex e.U, 2 Nomisma Healthcare, 3 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 2 Roquette, 6 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Sigachi Industries, 2 The Dow Chemical Company, 1 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

50 Coating Systems & Additives, 27 Controlled & Modified Release, 17 Fillers, Diluents & Binders, 12 Lubricants & Glidants, 11 Solubilizers, 11 Thickeners and Stabilizers, 9 Topical, 9 Film Formers & Plasticizers, 8 Granulation, 5 Direct Compression, 5 Empty Capsules, 5 API Stability Enhancers, 4 Coloring Agents, 4 Emulsifying Agents, 4 Rheology Modifiers, 4 Parenteral, 4 Disintegrants & Superdisintegrants, 4 Vegetarian Capsules, 2 Taste Masking, 1 Chewable & Orodispersible Aids, 1 Surfactant & Foaming Agents

50 Coating Systems & Additives
27 Controlled & Modified Release
17 Fillers, Diluents & Binders
12 Lubricants & Glidants
11 Solubilizers
11 Thickeners and Stabilizers
9 Topical
9 Film Formers & Plasticizers
8 Granulation
5 Direct Compression
5 Empty Capsules
5 API Stability Enhancers
4 Coloring Agents
4 Emulsifying Agents
4 Rheology Modifiers
4 Parenteral
4 Disintegrants & Superdisintegrants
4 Vegetarian Capsules
2 Taste Masking
1 Chewable & Orodispersible Aids
1 Surfactant & Foaming Agents

DIGITAL CONTENT

7 News #PharmaBuzz

7 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 Regulatory FDF Prices

4 Regulatory FDF Prices

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

1 USP
1 Others

$ API Ref.Price (USD/KG) : 936 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

4 All

01 4ABBVIE

filter Patent Number Reset all filters

4 All

01 47994220

filter API Patent Reset all filters

4 All

01 4Blank

filter FDF Patent Reset all filters

4 All

01 4Blank

filter Expiration Date Reset all filters

4 All

01 42029-09-19

Product Main Page

01

ABBVIE

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-19

MILNACIPRAN HYDROCHLORIDE

US Patent Number : 7994220

Drug Substance Claim :

Drug Product Claim :

Application Number : 22256

Patent Use Code : U-819

Delist Requested :

Patent Use Description : MANAGEMENT OF FIBROMYA...

Patent Expiration Date : 2029-09-19

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ABBVIE

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-19

MILNACIPRAN HYDROCHLORIDE

US Patent Number : 7994220

Drug Substance Claim :

Drug Product Claim :

Application Number : 22256

Patent Use Code : U-819

Delist Requested :

Patent Use Description : MANAGEMENT OF FIBROMYA...

Patent Expiration Date : 2029-09-19

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ABBVIE

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-19

MILNACIPRAN HYDROCHLORIDE

US Patent Number : 7994220

Drug Substance Claim :

Drug Product Claim :

Application Number : 22256

Patent Use Code : U-819

Delist Requested :

Patent Use Description : MANAGEMENT OF FIBROMYA...

Patent Expiration Date : 2029-09-19

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ABBVIE

Cancer Research

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-09-19

MILNACIPRAN HYDROCHLORIDE

US Patent Number : 7994220

Drug Substance Claim :

Drug Product Claim :

Application Number : 22256

Patent Use Code : U-819

Delist Requested :

Patent Use Description : MANAGEMENT OF FIBROMYA...

Patent Expiration Date : 2029-09-19

Abbvie Company Banner

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!